Meena PhD

SVP, Translational DMPK and Clinical Pharmacology at Stoke Therapeutics

Speaker

Meena is the Senior Vice President of Translational DMPK and Clinical Pharmacology at Stoke Therapeutics located in Bedford Massachusetts. Meena is helping in the development of medicines for genetic diseases including epilepsies like Dravet Syndrome. She has been working in the pharmaceutical industry for 20 years and has supported the development of treatments for Huntington’s Disease and Duchene Muscular Dystrophy. Prior to joining Stoke in 2018, Meena served as senior director of bioanalytical, pharmacology and biomarker development at Wave Life Sciences. She played a pivotal role in building Wave’s stereopure oligonucleotide chemistry platform and in guiding the clinical entry of three antisense programs. Earlier in her career, Meena worked at Alnylam Pharmaceuticals on siRNA chemistry and targeted siRNA delivery. Meena received her Ph.D. in chemistry with Dr. K.N. Ganesh at the National Chemical Laboratory in Pune, India, and did her postdoctoral research on nucleic acid analogs with Professor Larry W. McLaughlin at Boston College.